4.7 Article

Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Surfactant protein D: A useful biomarker for distinguishing COVID-19 pneumonia from COVID-19 pneumonia-like diseases

Yuki Togashi et al.

Summary: This study investigated the usefulness of serum Krebs von den Lungen 6 (KL-6) and surfactant protein D (SP-D) in distinguishing COVID-19 pneumonia from COVID-19 pneumonia-like diseases. The results showed that serum SP-D can more efficiently distinguish COVID-19 pneumonia from COVID-19 pneumonia-like diseases.

HEALTH SCIENCE REPORTS (2022)

Article Medicine, Research & Experimental

Baseline characteristics of COVID-19 Italian patients admitted to Desio Hospital, Lombardy: a retrospective study

Adela Sulejmani et al.

Summary: The study investigated the correlation between clinical, radiological and laboratory findings of COVID-19 patients at admission with disease severity and mortality risk. The most common comorbidity among patients was cardiovascular disease, and severe patients displayed higher levels of various indicators compared to non-severe patients. Factors such as older age, low PaO2/FIO2 ratio, clinical severity, and elevated creatinine and creatine kinase levels at admission were associated with increased mortality risk.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)

Review Immunology

SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties

Alastair Watson et al.

Summary: SP-A and SP-D are soluble innate immune molecules that play dual roles as anti-infectious and immunomodulatory agents, maintaining lung homeostasis. They have the potential to bind various viruses, including influenza A virus and RSV, modulating viral clearance and inflammatory response, thus showing therapeutic potential.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019

Jose Alberto Choreno-Parra et al.

Summary: Surfactant protein D (SP-D) may help differentiate severe pandemic influenza from COVID-19, with high serum SP-D levels possibly associated with death and renal failure in severe pandemic influenza cases. However, SP-D levels do not distinguish seasonal influenza from COVID-19 in mild-to-moderate disease.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity

Ming Tong et al.

Summary: The study indicated that the serum SP-D level in the early stage of COVID-19 was associated with disease severity, suggesting it could be a potential biomarker for identifying patients at risk of worsening condition.

BMC INFECTIOUS DISEASES (2021)

Article Virology

The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study

Handan Alay et al.

Summary: This study investigated the levels of serum surfactant-D (SP-D) and angiopoetin-2 (Ang-2) in predicting the severity of COVID-19 patients. The results showed that SP-D and Ang-2 levels were significantly higher in patients with more severe pneumonia, and they can serve as predictive factors in differentiating COVID-19 patients and determining disease severity.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Biochemistry & Molecular Biology

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

Raquel Arroyo et al.

Summary: SARS-CoV-2 infection of host cells is driven by the binding of the virus spike protein to lung cells, and the study aims to measure pulmonary SP-D levels in COVID-19 patients and demonstrate its activity against the virus. Results show that SP-D can bind to the SARS-CoV-2 spike protein, initiate aggregation, and inhibit viral replication in cells.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis

Tsukasa Okamoto et al.

RESPIRATORY MEDICINE (2015)

Article Immunology

Influenza A Viruses Target Type II Pneumocytes in the Human Lung

Viola K. Weinheimer et al.

JOURNAL OF INFECTIOUS DISEASES (2012)

Article Biochemistry & Molecular Biology

S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function

Chang-Jiang Guo et al.

PLOS BIOLOGY (2008)

Review Medicine, General & Internal

Surfactant protein D in human lung diseases

D Hartl et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Respiratory System

Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis

H Takahashi et al.

EUROPEAN RESPIRATORY JOURNAL (2001)

Article Critical Care Medicine

Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis

H Takahashi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)